Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Cardiovascular Diseases 1Cardiotoxicity 1Breast Neoplasms 1

Interventions

Aspirin 4Blood Pressure 3Vitamin E 2Vitamin D 2Nutrition Assessment 2Metformin 2Geritol 2Diet, Mediterranean 2Cholecalciferol 2phosphoribosylformylglycinamidine synthetase 1glycidol 1ficlatuzumab 1beta Carotene 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1Vorinostat 1Vascular Stiffness 1Tumor Necrosis Factor Inhibitors 1Therapeutics 1Sugars 1Spironolactone 1Resistance Training 1Raloxifene Hydrochloride 1Pulse Wave Analysis 1Progestins 1Physical Conditioning, Human 1Omeprazole 1Noninvasive Prenatal Testing 1Naproxen 1Methods 1Lysine Acetyltransferase 5 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Cardiovascular Diseases × Heart Function Tests × Clear all
NCT04568161 2025-04-03

Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses

University of Sao Paulo General Hospital

Phase NA Completed
15 enrolled
Breast

Breast Neoplasms, Cardiovascular Diseases, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡